Comparison of the live-attenuated japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: Similarities and differences in vitro and in vivo

Journal of General Virology

Volumn 97, Issue 10, 2016, Pages 2575-2591

  Yun, Sang Im ^a   Song, Byung Hak ^a   Polejaeva, Irina A ^a   Davies, Christopher J ^a   White, Kenneth L ^a   Lee, Young Min ^a  

^a UTAH STATE UNIVERSITY   (United States)

Author keywords

Japanese encephalitis virus; NS1; Ribosomal frameshift; SA14; SA14 14 2; Virulence

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOGENICITY; VIROLOGY; VIRULENCE;

AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; HUMANS; JAPANESE ENCEPHALITIS VACCINES; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS; VIRULENCE;

EID: 84991694028     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000574     Document Type: Article

References (63)

1. Aihara, S., Rao, C. M., Yu, Y. X., Lee, T., Watanabe, K., Komiya, T., Sumiyoshi, H., Hashimoto, H. & Nomoto, A. (1991). Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process. Virus Genes 5, 95-109.
2. Arroyo, J., Guirakhoo, F., Fenner, S., Zhang, Z. X., Monath, T. P. & Chambers, T. J. (2001). Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (Chi-meriVax-JE). J Virol 75, 934-942.
3. Assenberg, R., Mastrangelo, E., Walter, T. S., Verma, A., Milani, M., Owens, R. J., Stuart, D. I., Grimes, J. M. & Mancini, E. J. (2009). Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication. J Virol 83, 12895-12906.
4. Bollati, M., Alvarez, K., Assenberg, R., Baronti, C., Canard, B., Cook, S., Coutard, B., Decroly, E., de Lamballerie, X. & other authors (2010). Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res 87, 125-148.
5. Brinton, M. (2014). Replication cycle and molecular biology of the West Nile virus. Viruses 6, 13-53.
6. Brinton, M. A. & Basu, M. (2015). Functions of the 3¢ and 5¢ genome RNA regions of members of the genus Flavivirus. Virus Res 206, 108-119.
7. Calisher, C. H. & Gould, E. A. (2003). Taxonomy of the virus family Flavi-viridae. Adv Virus Res 59, 1-19.
8. Campbell, G. L., Hills, S. L., Fischer, M., Jacobson, J. A., Hoke, C. H., Hombach, J. M., Marfin, A. A., Solomon, T., Tsai, T. F. & other authors (2011). Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 89, 766-774.
9. Chambers, T. J., Nestorowicz, A., Mason, P. W. & Rice, C. M. (1999). Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J Virol 73, 3095-3101.
10. 14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease. Virology 366, 51-61.
11. 14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 6, 513-518.
12. Endy, T. P. & Nisalak, A. (2002). Japanese encephalitis virus: ecology and epidemiology. Curr Top Microbiol Immunol 267, 11-48.
13. Firth, A. E. & Atkins, J. F. (2009). A conserved predicted pseudoknot in the NS2A-encoding sequence of West Nile and Japanese encephalitis flavivi-ruses suggests NS1¢ may derive from ribosomal frameshifting. Virol J 6, 14.
14. Gebhard, L. G., Filomatori, C. V. & Gamarnik, A. V. (2011). Functional RNA elements in the dengue virus genome. Viruses 3, 1739-1756.
15. 14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice. Am J Trop Med Hyg 92, 98-107.
16. 14-14-2 that govern attenuation of virulence in mice. J Virol 89, 6328-6337.
17. Guirakhoo, F., Zhang, Z. X., Chambers, T. J., Delagrave, S., Arroyo, J., Barrett, A. D. & Monath, T. P. (1999). Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology 257, 363-372.
18. Halstead, S. B. & Thomas, S. J. (2011). New japanese encephalitis vac-cines: alternatives to production in mouse brain. Expert Rev Vaccines 10, 355-364.
19. Kaplan, E. L. & Meier, P. (1958). Nonparametric estimation from incom-plete observations. J Am Stat Assoc 53, 457-481.
20. Kato, Y., Sato, K., Asai, K. & Akutsu, T. (2012). Rtips: fast and accurate tools for RNA 2D structure prediction using integer programming. Nucleic Acids Res 40, W29-34.
21. Kim, J. M., Yun, S. I., Song, B. H., Hahn, Y. S., Lee, C. H., Oh, H. W. & Lee, Y. M. (2008). A single N-linked glycosylation site in the Japanese encephalitis virus prM protein is critical for cell type-specific prM protein biogenesis, virus particle release, and pathogenicity in mice. J Virol 82, 7846-7862.
22. Kim, J. K., Kim, J. M., Song, B. H., Yun, S. I., Yun, G. N., Byun, S. J. & Lee, Y. M. (2015). Profiling of viral proteins expressed from the genomic RNA of Japanese encephalitis virus using a panel of 15 region-specific polyclonal rabbit antisera: implications for viral gene expression. PLoS One 10, e0124318.
23. Kimura, T., Sasaki, M., Okumura, M., Kim, E. & Sawa, H. (2010). Flavi-virus encephalitis: pathological aspects of mouse and other animal models. Vet Pathol 47, 806-818.
24. Labeaud, A. D., Bashir, F. & King, C. H. (2011). Measuring the burden of arboviral diseases: the spectrum of morbidity and mortality from four prevalent infections. Popul Health Metr 9, 1.
25. 14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates. J Virol 87, 13694-13705.
26. 14-14-2. J Gen Virol 94, 2700-2709.
27. Lindenbach, B. D., Thiel, H. J. & Rice, C. M. (2007). Flaviviridae: the viruses and their replication. In Fields Virology, 5th edn. pp. 1101-1152. Edited by D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman & S. E. Straus. Philadelphia, PA: Lippincott Williams & Wilkins.
28. Liu, W. J., Zhu, M., Pei, J. J., Dong, X. Y., Liu, W., Zhao, M. Q., Wang, J. Y., Gou, H. C., Luo, Y. W. & Chen, J. D. (2013). Molecular phylogenetic and positive selection analysis of Japanese encephalitis virus strains isolated from pigs in China. Virus Res 178, 547-552.
29. Lu, G. & Gong, P. (2013). Crystal Structure of the full-length Japanese encephalitis virus NS5 reveals a conserved methyltransferase-polymerase interface. PLoS Pathog 9, e1003549.
30. Luo, D., Xu, T., Hunke, C., Grüber, G., Vasudevan, S. G. & Lescar, J. (2008). Crystal structure of the NS3 protease-helicase from dengue virus. J Virol 82, 173-183.
31. Mackenzie, J. S., Barrett, A. D. & Deubel, V. (2002). The Japanese encephalitis serological group of flaviviruses: a brief introduction to the group. Curr Top Microbiol Immunol 267, 1-10.
32. Mackenzie, J. S., Gubler, D. J. & Petersen, L. R. (2004). Emerging flavi-viruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10, S98-109.
33. Melian, E. B., Hinzman, E., Nagasaki, T., Firth, A. E., Wills, N. M., Nouwens, A. S., Blitvich, B. J., Leung, J., Funk, A. & other authors (2010). NS1’ of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasive-ness. J Virol 84, 1641-1647.
34. Monath, T. P. (2002). Japanese encephalitis vaccines and future prospects. Curr Top Microbiol Immunol 267, 105-138.
35. 14 and its attenuated vaccine derivatives. J Gen Virol 75, 1505-1510.
36. 14. J Gen Virol 76, 409-413.
37. 14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology 177, 541-552.
38. Paranjape, S. M. & Harris, E. (2010). Control of dengue virus translation and replication. Curr Top Microbiol Immunol 338, 15-34.
39. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty percent endpoints. Am J Hyg 27, 493-497.
40. Sato, K., Kato, Y., Hamada, M., Akutsu, T. & Asai, K. (2011). IPknot: fast and accurate prediction of RNA secondary structures with pseudoknots using integer programming. Bioinformatics 27, i85-93.
41. Schmittgen, T. D., Zakrajsek, B. A., Mills, A. G., Gorn, V., Singer, M. J. & Reed, M. W. (2000). Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 285, 194-204.
42. Solomon, T. (2006). Control of Japanese encephalitis-within our grasp? N Engl J Med 355, 869-871.
43. Song, B. H., Yun, S. I., Choi, Y. J., Kim, J. M., Lee, C. H. & Lee, Y. M. (2008). A complex RNA motif defined by three discontinuous 5-nucleo-tide-long strands is essential for Flavivirus RNA replication. RNA 14, 1791-1813.
44. 14-14-2, a live-attenuated Japanese encepha-litis vaccine that is currently available for humans. J Microbiol 50, 698-706.
45. Thiel, H. J., Collett, M. S., Gould, E. A., Heinz, F. X., Houghton, M., Meyers, G., Purcell, R. H. & Rice, C. M. (2005). Family flaviviridae. In Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of viruses, pp. 981-998. Edited by C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger & L. A. Ball. San Diego, CA: Elsevier Academic Press.
46. Wang, H. J., Li, X. F., Ye, Q., Li, S. H., Deng, Y. Q., Zhao, H., Xu, Y. P., Ma, J., Qin, E. D. & Qin, C. F. (2014). Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice. Vaccine 32, 949-956.
47. Weaver, S. C. & Barrett, A. D. (2004). Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol 2, 789-801.
48. Weaver, S. C. & Reisen, W. K. (2010). Present and future arboviral threats. Antiviral Res 85, 328-345.
49. Westaway, E. G., Mackenzie, J. M. & Khromykh, A. A. (2003). Kunjin RNA replication and applications of Kunjin replicons. Adv Virus Res 59, 99-140.
50. Wilder-Smith, A. & Halstead, S. B. (2010). Japanese encephalitis: update on vaccines and vaccine recommendations. Curr Opin Infect Dis 23, 426-431.
51. Winer, J., Jung, C. K., Shackel, I. & Williams, P. M. (1999). Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270, 41-49.
52. World Health Organization (2012). Recommendations to assure the quality, safety and efficacy of Japanese encephalitis vaccine (live, attenuated) for human use: replacement of WHO TRS No. 910 (Annex 3), pp. 1-89. Geneva, Switzerland: World Health Organization.
53. 14-14-2. Vaccine 32, 2675-2681.
54. 14-14-2) ablates NS1¢ formation and contributes to attenuation. J Gen Virol 93, 1959-1964.
55. 14-14-2 and their stabilities. Vaccine 28, 3635-3641.
56. 14-14-2 and its characteristics. In Encephalitis, pp. 181-206. Edited by S. Tkachev. InTech Open Access.
57. Yu, Y. X. & Wang, J. F. (1986). In vitro characteristics of attenuated Japanese encephalitis viruses. Chin J Virol 2, 197-201.
58. Yun, S. I. & Lee, Y. M. (2006). Japanese encephalitis virus: molecular biology and vaccine development. In Molecular Biology of the Flavivirus, pp. 225-271. Edited by M. Kalitzky & P. Borowski. Norwich: Horizon Scientific Press.
59. Yun, S. I. & Lee, Y. M. (2014). Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother 10, 263-279.
60. Yun, S. I., Kim, S. Y., Choi, W. Y., Nam, J. H., Ju, Y. R., Park, K. Y., Cho, H. W. & Lee, Y. M. (2003a). Molecular characterization of the full-length genome of the Japanese encephalitis viral strain K87P39. Virus Res 96, 129-140.
61. Yun, S. I., Kim, S. Y., Rice, C. M. & Lee, Y. M. (2003b). Development and application of a reverse genetics system for Japanese encephalitis virus. J Virol 77, 6450-6465.
62. Yun, S. I., Choi, Y. J., Song, B. H. & Lee, Y. M. (2009). 3’ cis-acting elements that contribute to the competence and efficiency of Japanese encephalitis virus genome replication: functional importance of sequence duplications, deletions, and substitutions. J Virol 83, 7909-7930.
63. Yun, S. I., Song, B. H., Kim, J. K., Yun, G. N., Lee, E. Y., Li, L., Kuhn, R. J., Rossmann, M. G., Morrey, J. D. & Lee, Y. M. (2014). A molecularly cloned, live-attenuated japanese encephalitis vaccine SA 14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice. PLoS Pathog 10, e1004290.